Jun-Jie Yin1, Bo Liang1, Xin-Rong Zhan1. 1. Department of Hematology, Xinxiang Central Hospital Xinxiang 453000, Henan Province, China.
Abstract
BACKGROUND: MicroRNAs (miRNAs) are a group of small non-coding RNAs that play important roles in the pathogenesis of human diseases by negatively regulating gene expression. The aim of this study was to explore the effect of miR-204 on cell proliferation migration and invasion in T-cell acute lymphoblastic leukaemia (T-ALL). METHOD: miR-204 expression was determined in bone marrow samples from 32 leukemia patients and 32 healthy controls by quantitative real-time PCR (qRT-PCR). The effect of miR-204 on cell proliferation was evaluated by CCK8 assay, cell migration and invasion were evaluated by transwell migration and invasion assays, In addition, the regulation of SOX4 by miR-204 was evaluated by luciferase reporter assay and western blot. RESULTS: our results revealed that miR-204 was low expressed in T-ALL. Cell proliferation assay showed that the cell proliferation ability was inhibited by miR-204 mimics. Moreover, migration and invasion assay suggested that overexpression of miR-204 could significantly suppressed the migration and invasion ability of T-ALL cells. Luciferase reporter assay confirmed that miR-204 directly bound to the 3' untranslated region of SOX4, and western blot suggested that miR-204 inhibited the expression of SOX4 at the protein levels. CONCLUSIONS: Our findings indicated that miR-204 negatively regulates SOX4 and inhibited proliferation, migration and invasion of T-ALL cell lines. Thus, miR-204 might represent a potential therapeutic target for T-ALL intervention.
BACKGROUND: MicroRNAs (miRNAs) are a group of small non-coding RNAs that play important roles in the pathogenesis of human diseases by negatively regulating gene expression. The aim of this study was to explore the effect of miR-204 on cell proliferation migration and invasion in T-cell acute lymphoblastic leukaemia (T-ALL). METHOD:miR-204 expression was determined in bone marrow samples from 32 leukemiapatients and 32 healthy controls by quantitative real-time PCR (qRT-PCR). The effect of miR-204 on cell proliferation was evaluated by CCK8 assay, cell migration and invasion were evaluated by transwell migration and invasion assays, In addition, the regulation of SOX4 by miR-204 was evaluated by luciferase reporter assay and western blot. RESULTS: our results revealed that miR-204 was low expressed in T-ALL. Cell proliferation assay showed that the cell proliferation ability was inhibited by miR-204 mimics. Moreover, migration and invasion assay suggested that overexpression of miR-204 could significantly suppressed the migration and invasion ability of T-ALL cells. Luciferase reporter assay confirmed that miR-204 directly bound to the 3' untranslated region of SOX4, and western blot suggested that miR-204 inhibited the expression of SOX4 at the protein levels. CONCLUSIONS: Our findings indicated that miR-204 negatively regulates SOX4 and inhibited proliferation, migration and invasion of T-ALL cell lines. Thus, miR-204 might represent a potential therapeutic target for T-ALL intervention.
Authors: Salemiz Sandoval; Christina Kraus; Er-Chieh Cho; Michelle Cho; Juraj Bies; Elena Manara; Benedetta Accordi; Elliot M Landaw; Linda Wolff; Martina Pigazzi; Kathleen M Sakamoto Journal: Blood Date: 2012-05-24 Impact factor: 22.113
Authors: Pieter Van Vlierberghe; Teresa Palomero; Hossein Khiabanian; Joni Van der Meulen; Mireia Castillo; Nadine Van Roy; Barbara De Moerloose; Jan Philippé; Sara González-García; María L Toribio; Tom Taghon; Linda Zuurbier; Barbara Cauwelier; Christine J Harrison; Claire Schwab; Markus Pisecker; Sabine Strehl; Anton W Langerak; Jozef Gecz; Edwin Sonneveld; Rob Pieters; Elisabeth Paietta; Jacob M Rowe; Peter H Wiernik; Yves Benoit; Jean Soulier; Bruce Poppe; Xiaopan Yao; Carlos Cordon-Cardo; Jules Meijerink; Raul Rabadan; Frank Speleman; Adolfo Ferrando Journal: Nat Genet Date: 2010-03-14 Impact factor: 38.330
Authors: Pedro P Medina; Sandra D Castillo; Sandra Blanco; Marta Sanz-Garcia; Cristina Largo; Sara Alvarez; Jun Yokota; Ana Gonzalez-Neira; Javier Benitez; Hans C Clevers; Juan C Cigudosa; Pedro A Lazo; Montse Sanchez-Cespedes Journal: Hum Mol Genet Date: 2009-01-19 Impact factor: 6.150
Authors: Nadezhda Palkina; Anna Komina; Maria Aksenenko; Anton Moshev; Andrei Savchenko; Tatiana Ruksha Journal: Oncol Lett Date: 2018-04-05 Impact factor: 2.967
Authors: T Yuan; Y Yang; J Chen; W Li; W Li; Q Zhang; Y Mi; R S Goswami; J Q You; D Lin; M D Qian; S Calin; Y Liang; R N Miranda; G A Calin; X Zhou; L Ma; P A Zweidler-McKay; B Liu; A P Weng; L J Medeiros; Y Zhang; M J You Journal: Leukemia Date: 2017-03-10 Impact factor: 11.528
Authors: Aleksandra Butrym; Piotr Łacina; Kazimierz Kuliczkowski; Katarzyna Bogunia-Kubik; Grzegorz Mazur Journal: BMC Cancer Date: 2018-01-30 Impact factor: 4.430